Resources

With rising global obesity rates and growing consumer interest in effective weight management solutions, the demand for scientifically substantiated weight loss products has never been greater. This white paper critically examines the complexity of weight loss, highlighting the limitations of popular claims and the need for rigorous clinical evidence. It...

Probiotics hold immense potential in optimizing gut health and redefining human wellness. This white paper explores the science behind the human microbiome, the evolving global probiotics market, and the regulatory complexities shaping claims in the U.S., Canada, and Europe. It highlights the critical role of well-designed clinical trials in substantiating...

With Canada becoming the first G7 nation to legalize recreational cannabis, this white paper from KGK Science examines the country's pioneering regulatory journey and its ripple effects on research, commerce, and consumer health. Backed by original survey data and regulatory analysis, the paper explores usage patterns, legislative milestones, clinical research...

The randomized controlled trial (RCT) has long been considered the gold standard in clinical research—but is it always the best fit for the complex, multi-targeted nature of dietary supplements? This thought-provoking white paper from KGK Science explores the limitations of traditional RCTs in the context of nutrition science and proposes...

As interest in probiotics surges, their inclusion in infant nutrition products has created both opportunity and controversy. This white paper explores the evolving regulatory landscape and growing scientific evidence surrounding probiotics in infant formulas and supplements. Authored by experts at KGK Science, it highlights the critical importance of well-designed clinical...